Literature DB >> 10863237

Lymphangioma-like Kaposi's sarcoma: etiology and literature review.

D A Davis1, D M Scott.   

Abstract

Much confusion surrounds a rare and occasionally described variant of Kaposi's sarcoma (KS) known as lymphangioma-like or bullous KS. We describe the typical clinical and histologic features and elucidate the etiologic cell in lymphangioma-like KS. A computer-based review of the English-language literature was performed. Routine histologic and immunoperoxidase techniques were performed on formalin-fixed tissue. Immunoperoxidase staining for anti-CD31, anti-CD34, and anti-factor VIII-related antigen suggests that the etiologic cell of origin is the vascular endothelial cell. Lymphangioma-like KS has been described for more than a century and given various names. Dilated vascular spaces correlate with the clinically bullous lesions, which are veritable KS and not a secondary reaction to it.

Entities:  

Mesh:

Year:  2000        PMID: 10863237     DOI: 10.1067/mjd.2000.105564

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Histopathological analysis of vesicular and bullous lesions in Kaposi sarcoma.

Authors:  Nilüfer Onak Kandemir; Figen Barut; Banu Doğan Gün; Nilgün Solak Tekin; Sevinç Hallaç Keser; Sükrü Oğuz Ozdamar
Journal:  Diagn Pathol       Date:  2012-08-15       Impact factor: 2.644

2.  Histological variants of cutaneous Kaposi sarcoma.

Authors:  Wayne Grayson; Liron Pantanowitz
Journal:  Diagn Pathol       Date:  2008-07-25       Impact factor: 2.644

3.  Lymphangiectatic Kaposi's sarcoma in a patient with AIDS.

Authors:  Mônica Santos; Virginia Vilasboas; Luciana Mendes; Carolina Talhari; Sinésio Talhari
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

4.  Cavernous hemangioma-like kaposi sarcoma: histomorphologic features and differential diagnosis.

Authors:  Nilüfer Onak Kandemir; Figen Barut; Banu Doğan Gün; Nilgün Solak Tekin; Sevinç Hallaç Keser; Sükrü Oğuz Özdamar
Journal:  Case Rep Med       Date:  2013-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.